Favorable Outcomes in FGFR Fusion-Positive Cholangiocarcinomas and Evolution on Treatment Noted on Circulating Tumor DNA Liquid Biopsies

Cholangiocarcinoma is a very heterogenous cancer and “target-rich” disease. While the current classifications are based on the anatomic location of these tumors (intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder cancer), tumors within and across these disease groups h...

Descripción completa

Detalles Bibliográficos
Autor principal: Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506383/
https://www.ncbi.nlm.nih.gov/pubmed/32999653
http://dx.doi.org/10.1159/000509075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506383/
https://www.ncbi.nlm.nih.gov/pubmed/32999653
http://dx.doi.org/10.1159/000509075

Ejemplares similares